STAT

Opinion: Should ‘broken’ genes be fixed? My daughter changed the way I think about that question

I’m a doctor. I strive to fix things that are broken. Hearts, mostly. But my daughter Ruthie has forever changed my thinking about what needs to be fixed.

Ruthie Weiss, our second daughter, arrived in this world with a shock of white hair. She reminded her mother, Palmer, and me of ourselves as blond children. A few days after we brought her home from the hospital, we nicknamed her Billy Idol.

Palmer began to notice that Ruthie’s eye didn’t track when she picked her up. I pooh-poohed that — spouting something about normal development being on a spectrum — until one day while changing Ruthie’s diaper I saw her eyes moving back and forth rhythmically, like the eyes in those red cat kitchen clocks that were once all the rage. My mind immediately jumped to something I had read in medical school.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly Buying A Plant, A Pfizer Antibiotic, And More
Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.

Related Books & Audiobooks